Overall, these results show that a 3-month clinical intervention of L-GSH supplementation in individuals with T2DM resulted in significantly increased levels of IFN-γ, TNF-α, IL-2, and decreased levels of IL-10 when compared to before L-GSH supplementation. This evidence concerns the gene IL10 and type 2 diabetes mellitus.